Post Profile

The FDA Just Approved A Drug To Treat 'Plague' (JNJ)

NEW BRUNSWICK, N.J. (AP) — U.S. regulators have approved use of a powerful Johnson & Johnson antibiotic to treat plague, an extremely rare, sometimes-deadly bacterial infection. The Food and Drug Administration also approved Levaquin, known generically as levofloxacin, to reduce risk of people getting plague after exposure to the bacteria that cause it. Called Yersinia pestis, the bacteria are considered a potential bioterrorism agent.
read more


Related Posts

FDA Approves Vibativ (Telavancin) For Bacterial Pneumonia

Health : Medical News Today

Vibativ (telavancin) has been approved by the FDA to treat HABP/VABP (hospital-acquired ventilator-associated bacterial pneumonia) caused by Staphylococcus aureus. The FDA (Food and Drug Administration) added that telavancin should ...

Levaquin Approved For Treating Plague, USA

Health : Medical News Today

Levaquin (levofloxacin) has been approved by the FDA for the treatment and prevention of the plague. Levofloxacin is a synthetic antibiotic of the fluoroquinolones drug class; it is currently used for the treatment of severe bacteri...

FDA Approves a New Drug To Treat HIV

Health : Time: Healthland

The Food and Drug Administration (FDA) approved a new drug to treat HIV infection on Friday. The drug, made by an arm of Johnson & Johnson, will be sold under the name Edurant, and is designed to be used in … Continue reading ?

FDA Approves First Generic Versions Of The Antibiotic Levofloxacin To Treat Certain Infections

Health : Medical News Today

The U.S. Food and Drug Administration approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older. Levofloxacin is used to treat mild, moderate, or s...

Generic Versions Of Antibiotic Levaquin (Levofloxacin) Approved By FDA

Health : Medical News Today

The FDA has approved some generic version of Johnson & Johnson's Levaquin (levofloxacin), an antibiotic used to treat mild, moderate and severe bacterial infections for adult patients. The FDA (Food and Drug Administration) has appr...


Copyright © 2016 Regator, LLC